Juawana Hall
Optometrist · Winston Salem, NCNPI 1659359537
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (33.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Alcon accounts for 81.7% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $26,418, more than ten times the $2,453 reported in 2019. Among optometrist clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 233 payments — averaging $261.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$50K
- Lumenis BE Inc$9K
- Coopervision Inc.$277
- Bausch & Lomb Americas Inc.$224
- Tarsus Pharmaceuticals, Inc.$165
- Alcon Research LLC$138
- plus $983 from 16 others
What the payments were for
- Consulting fees$18,43830%
- Speaking & faculty fees$20,27633%
- Travel & lodging$8,87815%
- Food & beverage$13,37822%
- Gifts$340%
- Entertainment$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 174 | $49,860 |
| Lumenis BE Inc | 3 | $9,375 |
| Coopervision Inc. | 9 | $277 |
| Bausch & Lomb Americas Inc. | 7 | $224 |
| Tarsus Pharmaceuticals, Inc. | 3 | $165 |
| Alcon Research LLC | 2 | $138 |
| Johnson & Johnson Vision Care, Inc. | 7 | $135 |
| Oyster Point Pharma, Inc. | 1 | $104 |
| Glaukos Corporation | 2 | $97 |
| Carl Zeiss Meditec USA, Inc. | 2 | $96 |
| Dompe US, Inc. | 4 | $95 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $76 |
| Rxsight Inc | 1 | $63 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $61 |
| Sun Pharmaceutical Industries Inc. | 2 | $51 |
| Optos, Inc. | 2 | $43 |
| Novartis | 2 | $41 |
| Shire North American Group Inc | 2 | $36 |
| Carl Zeiss Meditec AG | 2 | $34 |
| Lumenis, Inc | 1 | $21 |
| Kala Pharmaceuticals, Inc. | 1 | $18 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES TOTAL1$36,847
- TOTAL30$36,522
- Precision 1$31,135
- Precision7$22,285
- M22$4,774
- optilight$4,601
- AIR OPTIX$2,277
- DAILIES$1,869
- Dailies Aqua Comfort Plus$1,609
- Systane$500
- DAILIES TOTAL1 Multifocal$443
- XDEMVY$145
- Clareon$136
- MiSight Contact Lens$125
- TYRVAYA$104
How this compares
$61,022 in reported general payments places this provider in the 95th percentile of 1,326 optometrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 52 | $52,723 |
| XiidraLifitegrast | 12 | $12,941 |
| RocklatanNetarsudil Mesylat/Latanoprost | 11 | $3,790 |
| Alphagan PBrimonidine Tartrate | 12 | $2,354 |
| Latanoprost | 181 | $1,735 |
| Brimonidine Tartrate | 13 | $1,308 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 24 | $629 |
| Timolol Maleate | 28 | $271 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Alphagan P | $12 | $55,07764 claims |
| Bausch & Lomb Americas Inc.Xiidra | $224 | $12,94112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,326 optometrist providers in North Carolina.
Other optometrist in Winston Salem
- Crystal BrimerWilmington$920K
- Osama SaidRaleigh$597K
- Ryan CorteAsheville$569K
- Sanjay PatelApex$518K
- Sean SmolenyakRaleigh$512K
- Rachael WrubleBelmont$228K
- Lisa GreeneArden$186K
- Jennifer LyerlyMorrisville$164K
- Timothy PoirierKnightdale$130K
- Randall ThomasConcord$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.